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male infertility, TML appears to be related to an increased 
risk of testicular cancer possibly as part of a testicular dys-
genesis syndrome.
Keywords Testicular dysgenesis syndrome · Testicular 
microlithiasis · Testicular cancer · Ultrasonography
Introduction
Modern ultrasonography (US) gives more detailed infor-
mation than previously. As a consequence, testicular micro-
lithiasis (TML) is diagnosed more frequently. The origin of 
TML is unknown. Typically, TML is diagnosed by scrotal 
US performed for a variety of indications. Recently, it was 
demonstrated that both inter- and intraobserver agreement 
with regard to detecting TML with US is high [1]. TML is 
characterised by the presence of multiple microintratubular 
calcifications without any acoustic shadow in the testicle 
and is often an incidental finding in US examinations of the 
scrotum. The size of TML typically has a range of 1–3 mm 
[2].
Several studies deal with prevalence of TML in both 
asymptomatic and symptomatic men. Peterson et al. [3] 
reported a prevalence of 5.6 % in 1504 asymptomatic 
males (18–35 years old) from the US army reserve officer 
training corps. In another study of a 2179 asymptomatic 
males form a similar population, the prevalence was found 
to be 2.4 % [4]. Goede et al. [5] investigated 670 asymp-
tomatic boys in the age range 0–19 years and found a 
prevalence of 4.2 %. The reported prevalence in healthy 
populations in other series varies from 0.6 to 9.0 % [6–9]. 
In symptomatic males, the prevalence in general is higher 
than in asymptomatic males ranging from 8.7 to 18.1 % 
[10–12].
Abstract 
Purpose To perform a systematic literature review to 
assess whether the occurrence of testicular microlithiasis 
(TML) in conjunction with other risk factors is associated 
with testicular cancer.
Methods A systematic literature search was performed of 
original articles in English published 1998 to 2015. Rele-
vant studies were selected by reading the title and abstract 
by two of the authors. Studies were included if TML was 
diagnosed by ultrasonography and a risk condition was 
reported. Studies were only eligible if the particular risk 
condition was reported in more than one article.
Results In total, 282 abstracts in were identified. Based 
on title and abstract the eligibility was assessed and 31 
studies were included. Five conditions in relation to TML 
and testicular cancer emerged: Down syndrome, McCune–
Albright syndrome, cryptorchidism, infertility and familial 
disposition of testicular cancer.
Conclusion Data support the conclusion that TML is not 
an independent risk factor for testicular cancer but associ-
ated with testicular cancer through other conditions. In 
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TML has consistently been associated with carcinoma 
in situ (CIS) and testicular cancer; however, the relation is 
still controversial. In the literature, several independent con-
ditions have been reported to have very high frequencies of 
TML. If TML, as suggested by some authors, is the visible 
sign of a premalignant condition, one would expect that these 
disease states also would be associated with testicular cancer.
The aim of this paper was through a systematic literature 
review to evaluate whether TML, alone or in conjunction 
with other risk factors, is related to occurrence of testicular 
cancer.
Materials and methods
Search strategy
A literature search of original articles reporting on the rela-
tion between TML and specific conditions was performed 
using MEDLINE/PubMed starting January 2013 until 
January 2015. The included articles were published in the 
period from 1998 to 2015. The following keywords were 
used in the search strategy: testicular microlithiasis, micro-
lithiasis calcification. Review articles were used to iden-
tify other relevant studies through the snowball method. 
All abstracts were read though and only English-language 
articles were included. Relevant studies were selected 
by reading the title and the abstract by two of the authors 
(MRP and PJO).
Inclusion and exclusion criteria
Studies were included if TML was diagnosed by US and 
a risk condition was reported. Studies were only eligible 
if the particular risk condition was reported in more than 
one article. There were no criteria on number of patients 
enrolled in each study.
Included studies
The search strategy identified 344 abstracts, of which 282 
were in English. Of these, a total of 31 studies met the 
inclusion criteria. Two studies (Yee et al. [13] and Negri 
et al. [14]) had data on more than one risk condition (cryp-
torchidism and infertility). Seven studies investigated only 
children or adolescents and seven both men and boys and 
17 studies investigated men only. Tables 1, 2, 3, 4, 5 and 6 
present characteristics of the different studies.
Data extraction from the papers
Data were collected on study design, patient characteris-
tics, prevalence of TML, p value if available; country, num-
ber of patients enrolled and reported cancer cases.
Table 1  Characteristics of studies evaluating TML in Down syndrome
DS Down syndrome, TCDS testicular cancer in males with Down syndrome, TML testicular microlithiasis
a
 Ninety-two patients with Down syndrome, and 200 healthy controls. In the healthy controls, 14 men had TML; no TCs were found in control 
cases. One Leydig cell tumour was found in a male with Down syndrome with TML after 4-year follow-up
Author Year Country Mean age (range) N = DS N = TML and DS  
(prevalence)
N = total TCDS/TCDS 
with TML
Cebeci et al.
N = 50
2015 Turkey 2.4 (1–22) 25 9 (36.0 %) 0/0
Goede et al.
N = 79
2012 Netherlands 8.8 (0–18) 79 18 (22.8 %) 0/0
Vachon et al.
N = 92
2006 USA 10.7 (0–30) 92 27 (29.3 %) 1/1a
Table 2  Characteristics of studies evaluating TML in McCune–Albright syndrome
MAS McCune–Albright syndrome, TCMAS testicular cancer in males with McCune–Albright syndrome, TML testicular microlithiasis
NR  Not reported
a
 One male with MAS was reported with an embryonal cell tumour, and 5 years later with a seminoma in the contralateral testis. There was no 
information on TML in this case
Author Year Country Mean age  
(range)
N = MAS N = TML and MAS  
(prevalence)
N = total TCMAS/TCMAS 
with TML
Boyce et al.
N = 54
2012 USA NR (3–59) 54 13 (24.1 %) 1/0a
Wasniewska et al.
N = 40
2004 Italy 13.9 (5–21) 8 5 (62.5 %) 0/0
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Statistics
Z-test was used to evaluate differences in proportions 
between groups.
Results
In analysing the association between TML and possible 
conditions, five conditions had been studied. Three stud-
ies referred to Down syndrome, two referred to McCune–
Albright syndrome, nine referred to cryptorchidism, seven-
teen referred to infertility, and two studies dealt with familial 
disposure to testicular cancer (Tables 1, 2, 3, 4, 6). In the 
following section, we discuss the relationship between TML 
and malignancy in relation to these conditions (Fig. 1). 
Down syndrome
The three studies concerning TML and Down syndrome 
(DS) were conducted in children (Table 1). The boys with 
Down syndrome had higher prevalence of TML than the 
general healthy population. The prevalence of TML was 
reported between 22.8 and 36.0 %, compared to 0–7 % in 
healthy controls [15–17]. The overall prevalence of TML in 
DS was 27.6 %. No case of testicular cancer was recorded 
among 142 DS men with TML. Only one study found a tes-
ticular cancer (Leydig Cell tumour) in an individual with 
DS and TML (1/54 = 1.9 %), and the cancer was diag-
nosed during the fourth year of follow-up.
McCune–Albright syndrome
McCune–Albright Syndrome (MAS) is a congenital dis-
ease characterised by polyostotic fibrous dysplasia, café-
au-lait pigmentation and early puberty. Two studies were 
included concerning TML and MAS. Both studies included 
boys and men (Table 2). The prevalence of TML in MAS 
males was 24.1 % [18] and 62.5 % [19]. Combining both 
studies, the prevalence was 29.0 %. One testicular cancer 
(embryonal cell tumour) was reported among 62 cases of 
MAS [18], with no known risk factors or TML.
Cryptorchidism
Our search resulted in nine studies of cryptorchidism and 
TML (Table 3). In four series of cryptorchidism reported 
the frequencies of TML were 100 % [20], 3.9 % [21], 
2.8 % [22] and 7.1 % [23]. No testicular malignancy was 
reported. One series [14] found an association of the previ-
ous cryptorchidism and an increased risk of testicular can-
cer (odds ratio 7.5), but there was no information linking 
TML to the cancer cases (Table 3). In the study of Cooper 
et al., nine patients with cryptorchidism and TML were 
found, and three of these were diagnosed with intratubular 
germ cell neoplasia [24].
Infertility
We included seventeen studies concerning infertility 
(Table 4). The prevalence of TML in infertile men varied 
Table 3  Characteristics of studies evaluating TML in cryptorchidism
C cryptorchidism, NR not reported, TCC testicular cancer in males with cryptorchidism, TML testicular microlithiasis
Author Year Country Mean age  
(range)
N = C N = TML and C  
(prevalence)
N = total TCC/TCC 
with TML
Cooper et al.
N = 3370
2014 USA 11 (1–18) 9 9 (100 %) 10/3
Chiang et al.
N = 31
2012 Singapore NR (5–15) 12 12 (100 %) 0/0
Dutra et al.
N = 1504
2011 Brazil 7.5 (1–5) 127 5 (3.9 %) 0/0
Yee et al.
N = 1439
2011 Korea 19.1 (0–87) 310 7 (2.3 %) NR
Goede et al.
N = 501
2010 Netherlands 12.5 (3–29) 501 14 (2.8 %) 0/0
Negri et al.
N = 2172
2008 Italy 37 (20–62) 232 23 (9.9 %) NR
Kosan et al.
N = 197
2007 Turkey 28.3 (NR) 8 2 (25 %) NR
Konstantinos et al.
N = 391
2006 Greece 37 (15–76) 36 2 (5.5 %) 0/0
Patel et al.
N = 112
2005 USA 19.6 (18–29) 112 8 (7.1 %) 0/0
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Table 4  Characteristics of studies evaluating TML and male infertility
NR not reported, CIS carcinoma in situ, TCI testicular cancer, TML testicular microlithiasis
a
 For cancer subtypes please refer to Table 5
Author Year Country Mean age  
(range)
N = infertile N = TML in infertile 
(prevalence)
N = total TCI/TCI 
with TML
Jiang et al.
N = 22
2012 China 31.6 (25–40) 22 22 (100 %) 0
La Vignera et al.
N = 1056
2012 Italy 43.3 (0.3–87) 320 60 (18.8 %) 15/10a
Yee et al.
N = 1429
2011 Korea 19.1 (0–87) 60 10 (16.6 %) 47/10
Zhang et al.
N = 34
2010 China 31.1 (NR) 34 17 (50 %) 0/0
Negri et al.
N = 2172
2008 Italy 37 (19.8–61.9) 415 17 (4.1 %) 14/NR
Ou et al.
N = 1978
2007 Taiwan 32 (1–88) 12 4 (33.3 %) 17/9a
Parenti et al.
N = 14
2007 Italy NR (19–43) 2 0 (0 %) 11/2
Qublan et al.
N = 384
2006 Jordan 31 (21–63) 234 23 (9.8 %) 0/0
Sakamoto et al.
N = 969
2006 Japan 40.9 (20–97) 550 31 (5.6 %) 0/0
Sakamoto et al.
N = 545
2006 Japan 35.8 (22–56) 545 30 (5–5 %) 1/0
Mazzilli et al.
N = 303
2005 Italy NR (29–51) 281 13 (4.6 %) 0/0
Brazao et al.
N = 263
2004 Netherlands NR (NR) 263 53 (20 %) 7 CIS/6 CISa
Von Eckardstein et al.
N = 1701
2001 Germany NR (NR) 1399 32 (2.3 %) NR/2 CISa
Thomas et al.
N = 159
2000 UK NR (NR) 159 10 (6.3 %) 0/0
Pierik et al.
N = 1372
1999 Netherlands NR (20–58) 1372 12 (0.9 %) 7/0
Ganem et al.
N = 22
1999 USA 29 (8–63) 5 5 (100 %) 8/2a
Aizenstein et al.
N = 180
1998 USA 37 (31–49) 180 5 (2.8 %) 0/0
Table 5  Cancer subtypes reported in patients with testicular tumours and TML
IGCN/CIS intratubular germ cell neoplasia/carcinoma in situ
Cancer subtype Risk factor Total (%)
Down syndrome McCune–Albright  
syndrome
Cryptorchidism Infertility
Seminoma – – 6 24 30 (36)
Mixed germ cell tumour – – 6 11 17 (20)
Leydig cell tumour 1 – – 8 9 (11)
Teratoma – – 2 4 6 (7)
Yolk sac tumour – – 1 1 2 (3)
Embryonal carcinoma – – 1 1 (1)
IGCN/CIS – – 3 15 18 (22)
Total 1 18 64 83
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between 0.9 and 18.8 %, compared to 2.3–9.8 % in studies 
who also included fertile men [14, 25–29]. By pooling the 
data, the overall prevalence of TML was 6.0 and 4.8 % in 
infertile and fertile men, respectively (p < 0.05). The rela-
tion between testicular cancer and TML was inconsistently 
reported. In the following analysis, only studies reporting 
both cancer cases and TML are considered. In total, 44 can-
cers were reported in 5092 infertile males (0.90 %) com-
pared to 52 cancers in 2889 fertile men (1.8 %) (p < 0.01) 
[13, 14, 25–35]. Analysing the relation between TML 
and testicular cancer (including CIS) in infertile men, the 
pooled data revealed that the cancer prevalence of infertil-
ity plus TML was 10.9 and 1.6 % in case of infertility with-
out TML (p < 0.001). Correspondingly, the cancer preva-
lence of fertility plus TML was 6.1 % compared to 2.6 % 
in fertile men without TML (NS). Comparing cancer preva-
lence between infertility plus TML and fertility plus TML, 
there was only a weak trend towards a higher cancer rate 
among the infertile TML men. Cancer subtypes in infertile 
men with TML are presented in Table 5.
Familial disposition to testicular cancer
Two studies concerning TML and family history of tes-
ticular cancer were identified (Table 6). Both studies were 
conducted prospectively in adults with TML prevalence 
between 48.0 to 36.7 %. Korde et al. [36] found that TML 
was more frequent in the contralateral testis of men with a 
history of testicular germ cell tumours and that TML was 
more prevalent among family members than previously 
described in the general population. Eighty-one men (48 
with testicular cancer and their 33 unaffected relatives) 
from 31 families were investigated; 14 had brothers with 
testicular cancer; 6 had fathers with testicular cancer; 3 
cousins with testicular cancer; and 8 had more than two 
affected family members with testicular cancer. The preva-
lence of TML was significantly higher among cases than 
among unaffected men (48 vs. 24 %; p = 0.04). No can-
cer was found in the group of relatives with TML (8 of 33 
relatives).
Coffey et al. [37] analysed ultrasound data of 328 men 
(169 testicular cancer cases; 58 relatives to the cases; 101 
controls). A greater concordance for TML in relatives of 
testicular cancer cases than would be expected was dem-
onstrated. No testicular cancer case was found in the group 
of relatives, whereas one testicular cancer was found in the 
control group and three in the remaining testis of the case 
group (Table 5). Overall TML was present with a higher 
frequency in cases with prior testicular cancer (36.7 %) 
compared to controls (17.8 %).
Discussion
Males with Down syndrome and McCune–Albright syn-
drome appear to have the highest frequencies of TML, 
Table 6  Characteristics of studies evaluating TML in males with familial disposition to testicular malignancy
NR not reported, TCF testicular cancer in males with familial disposition, TML testicular microlithiasis
a
 Forty-eight affected males and 33 unaffected male blood relatives from 31 multiple-case testicular germ cell tumour families. TML was found 
in 8 of 33 unaffected males and in 23 of 48 affected males
b
 A total of 169 cancer cases found (76 seminoma, 92 non-seminoma and one of unknown origin) and four developed a second tumour (two 
seminoma and two CIS), but no information if any had TML. No cancers found in the 58 relatives, and 1 cancer was diagnosed in the 101 con-
trol cases, but no information if TML or not
Author Year Country Mean age (range) N = Cancer cases N = TML (prevalence) N = TCF/TCF with TML
Korde et al.
N = 81
2008 UK 39 (NR) 48 23 (48 %) 0/0a
Coffey et al.
N = 328
2007 UK 47 (25–78) 169 62 (36.7 %) NRb
Fig. 1  An ultrasonography of a 16-year-old male with testicular can-
cer and multiple TML diagnosed in 2014 in our Department of Radi-
ology. The longitudinal size of the tumour was 1.6 cm
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ranging from 23 to 63 %. The present analysis revealed that 
in these conditions there seemed to be no relation between 
TML and development of testicular cancer. This observa-
tion questions TML as an independent risk factor for tes-
ticular malignancy. Males with Down syndrome had higher 
risk of testicular cancer [38, 39], and possibly decreased 
spermatogenesis [40], but from the present analysis TML 
does not seem to be related to higher risk of malignancy. 
Individuals with MAS are often affected by hormonal dis-
orders such as early puberty, which also is the case among 
males with Down syndrome. This association between 
TML and chromosomal abnormalities may indicate TML 
as part of a degenerative process of the testis.
Cryptorchidism is associated with increased risk of tes-
ticular cancer [41–44]. As seen from the present analysis, 
there is, however, no clear evidence whether TML and 
cryptorchidism or TML and testicular cancer are inter-
linked. However, as TML-related cancer risk in cryptor-
chidism was inconsistently reported, further studies are 
warranted.
Infertility is a risk factor for testicular cancer [45–47]. 
Numerous studies have suggested the association between 
testicular malignancy, TML and infertility [7, 36, 37, 48]. 
The prevalence of TML in infertile men is generally higher 
than in fertile men [6–9, 13, 30]. Our analysis showed 
that TML was associated with an approximated sevenfold 
higher cancer risk compared to infertile men without TML 
(10.9 vs. 1.6 %), confirming that TML, infertility and tes-
ticular cancer seem to be interlinked. Thus, TML may be 
an indicator of a “testicular dysgenesis syndrome”, consist-
ing of infertility, cryptorchidism, CIS and testicular cancer 
[49].
Families with both TML and testicular malignancy have 
been reported [36, 37], as well as TML in siblings [50]. 
In the two included studies, 28 relatives with TML were 
found, but no cancer cases reported. The relative risk of 
developing testicular cancer if ones brother is diagnosed 
with testicular germ cell tumour is 8–10 times higher [51, 
52]. A higher TML frequency among family members 
may be due to both genetics and shared exposures. Preva-
lence of TML in male blood relatives has been reported as 
high as 48 % [37]. The high prevalence may be an indica-
tor of a genetic factor rather than exposure due to the high 
prevalence in TML families. Also, TML cluster in certain 
families has been suggested to be linked to development of 
testicular germ cell tumours [36, 37]. The present analysis 
questions this, since no testicular cancers were reported 
among TML blood relatives. Further studies are needed 
to clarify whether a family relation with regard to TML 
increases risk of testicular cancer.
Our review highlights that TML cannot be viewed 
isolated, as current clinical practice has tended to do. 
Decisions on clinical management should be based on 
associated risk factors, a point of view that has been sup-
ported by recent papers [53, 54]
With regard to cancer subtypes, data in the literature 
are sparse, and as evident from our analysis, cancer sub-
types were inconsistently reported (Table 5). Recently, it 
was suggested that there might be a positive association 
between TML and seminoma, and a negative association 
between TML and embryonal cell carcinoma. This was 
confirmed in our review, in which seminoma accounted 
for 36 % of cancer cases reported with TML compared 
to 1 % for embryonal carcinoma (Table 5). There appears 
to be no association between TML, age and tumour size 
[55].
Holm et al. [56] compared clinical and histological data 
regarding the contralateral testicle in a population of men 
diagnosed with testicular germ cell cancer to find features 
associated with an increased risk of bilateral neoplasia. 
Ultrasound examination of the contralateral testicle was 
performed in 64 cases. They found that the frequency of 
TML seen on ultrasound was significantly higher among 
patients with CIS compared to those with a normal echo 
pattern. They concluded that the finding of contralateral 
TML on ultrasound in a patient with testicular germ cell 
cancer increases the risk of harbouring CIS in that testicle 
(odds ratio 28.6; CI 4.8–170.4). On the other hand, a nor-
mal ultrasound pattern does not exclude the risk of CIS and 
as evident from the present analysis, whether sonographic 
TML found in other subgroups of patients or in men from 
the general population also implies an increased risk of 
testicular CIS remains questionable. In the present review 
CIS/Intratubular Germ Cell Neoplasia accounted for 22 % 
of reported tumours with TML.
The main limitation of the present analysis is that the 
included studies had different objectives, which may have 
resulted in selection bias and misrepresentation of the rela-
tion between TML and testicular cancer. Furthermore, 
results in adults and boys may not be comparable.
Data in the literature seem to support the conclusion that 
TML is not an independent risk factor for testicular can-
cer. In male infertility, TML appears to be related to an 
increased risk possibly as part of a testicular dysgenesis 
syndrome. Many of the findings may simply be due to sur-
veillance bias as some groups are further examined.
Further longitudinal clinical studies are required to 
evaluate the true relationship between TML and testicular 
cancer. Evaluation of other imaging modalities, for instance 
MRI, may help in defining subgroups of TML patients at 
special risk of malignant development.
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